Eagle Pharmaceuticals Inc (EGRX) USD0.001
Sell:$0.51Buy:$0.51
$0.01
(1.88%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISA
Fund and Share AccountSell:$0.51
Buy:$0.51
Change:$0.01
(1.88%)
$0.01
(1.88%)Prices delayed by at least 15 minutes
Sell:$0.51
Buy:$0.51
Change:$0.01
(1.88%)
$0.01
(1.88%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 28 February 2024 | Scott L. TarriffChairman/CEO | Sell Tax related | 2,119 | $6.27 | $13,286.13 | 460,621 |
| 27 February 2024 | Scott L. TarriffChairman/CEO | Sell Tax related | 3,154 | $6.44 | $20,311.76 | 462,740 |
| 27 February 2024 | Brian Joseph CahillCFO | Sell Tax related | 1,589 | $6.44 | $10,233.16 | 47,958 |
| 2 February 2024 | Brian Joseph CahillCFO | Sell Tax related | 934 | $5.85 | $5,463.90 | 45,747 |
| 5 January 2024 | Scott L. TarriffChairman/CEO | Sell Tax related | 4,322 | $5.13 | $22,171.86 | 541,125 |
| 5 January 2024 | Brian Joseph CahillCFO | Sell Tax related | 735 | $5.13 | $3,770.55 | 46,681 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 5 January 2024 | Scott L. TarriffChairman/CEO | Sell Tax related | 4,322 | $5.13 | $22,171.86 | 541,125 |
| 27 February 2024 | Scott L. TarriffChairman/CEO | Sell Tax related | 3,154 | $6.44 | $20,311.76 | 462,740 |
| 28 February 2024 | Scott L. TarriffChairman/CEO | Sell Tax related | 2,119 | $6.27 | $13,286.13 | 460,621 |
| 27 February 2024 | Brian Joseph CahillCFO | Sell Tax related | 1,589 | $6.44 | $10,233.16 | 47,958 |
| 2 February 2024 | Brian Joseph CahillCFO | Sell Tax related | 934 | $5.85 | $5,463.90 | 45,747 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.